Literature DB >> 25585598

Methylcobalamine is effective in peripheral neuropathies.

S U Naik1, D V Sonawane1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25585598     DOI: 10.1038/ejcn.2014.281

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


× No keyword cloud information.
  8 in total

Review 1.  [Old or new medicine? Vitamin B12 and peripheral nerve neuropathy].

Authors:  Hiroyuki Tanaka
Journal:  Brain Nerve       Date:  2013-09

Review 2.  Peripheral neuropathy: pathogenic mechanisms and alternative therapies.

Authors:  Kathleen A Head
Journal:  Altern Med Rev       Date:  2006-12

3.  Treatment of vitamin B12 deficiency-methylcobalamine? Cyancobalamine? Hydroxocobalamin?-clearing the confusion.

Authors:  K Thakkar; G Billa
Journal:  Eur J Clin Nutr       Date:  2014-08-13       Impact factor: 4.016

4.  Olestra dose response on fat-soluble and water-soluble nutrients in the pig.

Authors:  D A Cooper; D A Berry; V A Spendel; D King; A L Kiorpes; J C Peters
Journal:  J Nutr       Date:  1997-08       Impact factor: 4.798

5.  Methylcobalamin, but not methylprednisolone or pleiotrophin, accelerates the recovery of rat biceps after ulnar to musculocutaneous nerve transfer.

Authors:  W-C Liao; J-R Chen; Y-J Wang; G-F Tseng
Journal:  Neuroscience       Date:  2010-09-25       Impact factor: 3.590

6.  Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy.

Authors:  Houliang Deng; JinJin Yin; JingJing Zhang; Qian Xu; Xiaoxia Liu; Li Liu; Zhuomin Wu; Aimin Ji
Journal:  Endocrine       Date:  2014-02-13       Impact factor: 3.633

7.  Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy: a phase I/II open label clinical trial.

Authors:  Kazumoto Shibuya; Sonoko Misawa; Saiko Nasu; Yukari Sekiguchi; Minako Beppu; Yuta Iwai; Satsuki Mitsuma; Sagiri Isose; Kimiyoshi Arimura; Ryuji Kaji; Satoshi Kuwabara
Journal:  Intern Med       Date:  2014-09-01       Impact factor: 1.271

8.  Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study.

Authors:  D Vasudevan; Manoj M Naik; Qayum I Mukaddam
Journal:  Ann Indian Acad Neurol       Date:  2014-01       Impact factor: 1.383

  8 in total
  1 in total

1.  A randomized, open labeled study comparing the serum levels of cobalamin after three doses of 500 mcg vs. a single dose methylcobalamin of 1500 mcg in patients with peripheral neuropathy.

Authors:  Amrita Sil; Hrishikesh Kumar; Rahul Deb Mondal; Sidharth Sankar Anand; Anirban Ghosal; Ashis Datta; Sandesh V Sawant; Vaibhavi Kapatkar; Ganesh Kadhe; Sameer Rao
Journal:  Korean J Pain       Date:  2018-07-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.